Related Content

• Conditions (26): Agenesis of Corpus Callosum, Dandy Walker Syndrome, Pachygyria, and 23 others Agenesis of Corpus Callosum, Dandy Walker Syndrome, Pachygyria, Hydrocephalus, Friedreich's Ataxia, Autism / Autism Spectrum, Diseases and Conditions, Angelman syndrome, Lissencephaly, Cerebral Palsy, Arnold-Chiari Malformation, Spina Bifida, Genetic and Rare Conditions, Sturge-Weber syndrome, Brown-Sequard syndrome, Joubert syndrome, Tuberous Sclerosis, Brain and Nervous System, Achalasia, Hirschsprung's Disease, Trimethylaminuria, Addison's Disease, Anencephaly, Dercum's Disease, PANDA Syndrome, Fragile X Syndrome [hide]
• Groups (37): Empty Sella Syndrome, Agenesis of Corpus Callosum, Dandy Walker Syndrome, and 34 others Empty Sella Syndrome, Agenesis of Corpus Callosum, Dandy Walker Syndrome, Pachygyria, Anencephaly, hydrocephalus, Trigeminal Neuralgia, Arnold Chiari Malformation, Spinal Stenosis, Friedreich's Ataxia, Hashimoto's Encephalopathy, Tourette Syndrome, Parkinson's Disease, Wernicke-Korsakoff Syndrome, Achalasia, Rare 'Orphan' Disorders, Hirschsprung's Disease, PANDAS Syndrome, Trimethylaminuria, Dercum's Disease, Addison's Disease, Blepharophimosis, Fragile X Syndrome, Ledderhose Disease, Aarskog Syndrome, Legg-Calve-Perthes Disease, Microphthalmia, Darier's Disease, Cri-du-Chat Syndrome, Behcet's Syndrome, 1p36 Deletion Syndrome, Cleidocranial Dysplasia, Fructose Intolerance, Cushing's Syndrome, Kartagener Syndrome, Menkes Kinky Hair Syndrome, Short Bowel Syndrome [hide]
• Symptoms (17): Blepharophimosis, Sweet Syndrome, Club Foot, and 14 others Blepharophimosis, Sweet Syndrome, Club Foot, Von Willebrand disease, Scleroderma, Wernicke-Korsakoff Syndrome, Castleman's Disease, pyoderma gangrenosum, Intracranial Pressure, Tetralogy of Fallot, Ataxia, Polymicrogyria, Tethered Spinal Cord, Glioma, neuropathy, Enlarged Sella Turcica, Brain stem dysfunction [hide]
• Treatments (26): Bromocryptine, Mastectomy, ARGININE 364 MG, and 23 others Bromocryptine, Mastectomy, ARGININE 364 MG, PERIPHRAMINE INJ, ARGININE 5.09 MG/ML, AMINOSYN II 4.25%/DEXTROSE 20% INJ, ARGININE 600 MG/100ML, AMINOSYN 3.5%/DEXTROSE 5% INJ, ARGININE 730 MG/100ML, AMINOSYN 5% INJ, AMINOSYN II 8.5% INJ, AMINOSYN-HBC 7% INJ, AMINOSYN 7%/ELECTROLYTES INJ, AMINOSYN-PF 7% INJ, ARGININE 0.58 GM, PROCALAMINE INJ, ARGININE 1018 MG/100ML, FREAMINE 6.9% HBC INJ, ARGININE 14.7 MG/ML, TRAVASOL 8.5%/ELECTROLYTES INJ, ARGININE 3.1 MG, AMINOSYN II 15% INJ,BULK,2000ML, ARGININE 850 MG, ARGININE 950 MG/100ML, ARGININE HYDROCHLORIDE 700 MG, AMINOSYN 8.5% W/ELECTROLYTES INJ [hide]

About Empty Sella Syndrome

Empty sella syndrome (abbreviated ESS) is a disorder that involves the sella turcica, a bony structure at the base of the brain that surrounds and protects the pituitary gland. ESS is a condition that is often discovered during tests for pituitary disorders, when radiological imaging of the pituitary gland... more

Empty sella syndrome (abbreviated ESS) is a disorder that involves the sella turcica, a bony structure at the base of the brain that surrounds and protects the pituitary gland. ESS is a condition that is often discovered during tests for pituitary disorders, when radiological imaging of the pituitary gland reveals a sella turica that appears to be empty. There are two types of ESS: primary and secondary. Primary ESS happens when a small anatomical defect above the pituitary gland increases pressure in the sella turica and causes the gland to flatten out along the interior walls of the sella turica cavity. Primary ESS is associated with obesity and high blood pressure in women. The disorder sometimes results in a build-up of fluid pressure inside the skull and the pituitary gland may be smaller than usual. Secondary ESS is the result of the pituitary gland regressing within the cavity after an injury, surgery, or radiation therapy. Individuals with secondary ESS due to destruction of the pituitary gland have symptoms that reflect the loss of pituitary functions, such as the ceasing of menstrual periods, infertility, fatigue, and intolerance to stress and infection. In children, ESS may be associated with early onset of puberty, growth hormone deficiency, pituitary tumors, or pituitary gland dysfunction. MRI scans are useful in evaluating ESS and differentiating it from other disorders that produce an enlarged sella.

Treatment

Unless the syndrome results in other medical problems, treatment for endocrine dysfunction associated with pituitary malfunction is symptomatic and supportive. In some cases, surgery may be needed.

less